An Act To Reduce Morbidity and Mortality Related to Injected Drugs
Maine Legislature, Session 127, LD 1552
Committee Amendment CA_A_H559 (House)
Amends: 22 MRSA §1341

COMMITTEE AMENDMENT "A" to H.P. 1057, L.D. 1552, Bill, "An Act To 
Reduce Morbidity and Mortality Related to Injected Drugs" 
Amend the bill by striking out all of section 1 and inserting the following: 
'Sec. 1. 22 MRSA §1341, sub-§§1 and 2, as amended by PL 2007, c. 346, Pt. A, 
§ 1, are further amended to read: 
1. 
Certification of programs. 
The Maine Center for Disease Control and 
Prevention may certify hypodermic apparatus exchange programs that meet the 
requirements established by rule under subsection 2, paragraphs A to D. 
A. The Maine Center for Disease Control and Prevention may not limit the number 
of hypodermic apparatuses provided by the programs to participants. 
B. The Maine Center for Disease Control and Prevention may not limit the number 
of hypodermic apparatuses that participants served by the programs may legally 
possess, transport or exchange. 
2. Rules. The Maine Center for Disease Control and Prevention shall adopt rules 
pursuant to the Maine Administrative Procedure Act establishing requirements for 
hypodermic apparatus exchange programs and for program certification requirements. 
The rules must include but are not limited to: 
A. Procedures for the safe disposal of hypodermic apparatuses; 
B. Tracking the number of hypodermic apparatuses distributed and collected; 
C. Drug abuse prevention and treatment education; aoo 
D. Measl:H'es to aiseol:H'age the 1:1tili,3atioa of Distribution of educational material 
regarding the dangers associated with the use of used hypodermic apparatuses~~ 
E. Application procedures for a certified hypodermic apparatus exchange program to 
apply for funds to operate the program including the purchase and disposal of 
hypodermic needles; 
COMMITTEE AMENDMENT 
!, fo, 
~ ~-
COMMITTEE AMENDMENT'A "to H.P. 1057, L.D. 1552 
F. 
Criteria for the award of funds to certified hypodermic apparatus exchange 
programs; 
G. Oversight of certified hypodermic apparatus exchange programs; 
H. 
Renewal ever:y 5 years of department certification of hypodermic apparatus 
exchange programs; 
I. Complaint investigation procedures; and 
J. Criteria for decertification of hypodermic apparatus exchange programs. 
Rules adopted or amended pursuant to this section are routine technical rules as defined 
in Title 5, chapter 375, subchapter 2-A. 
Sec. 2. 22 MRSA §1341, sub-§4 is enacted to read: 
4. 
Funding. 
This subsection governs the use of state funds for hypodermic 
apparatus exchange programs certified pursuant to this section. This subsection is not 
intended to limit the ability of certified programs to secure other sources of funding or to 
discourage fund-raising for the pumose of operating such programs. The Maine Center 
for Disease Control and Prevention shall allocate any funds appropriated for hypodermic 
apparatus exchange programs among new and existing certified programs based on rates 
of intravenous drug use and negative health outcomes related to drug use in the 
geographic area surrounding a program; if applicable, the amount of services historically 
provided by the certified program; and other relevant factors. The award of funds must 
occur not later than 60 days after the effective date of this subsection and annually 
thereafter based on the availability of funding.' 
Amend the bill by relettering or renumbering any nonconsecutive Part letter or 
section number to read consecutively. 
SUMMARY 
The amendment makes the following changes to the bill. 
1. It adds language to indicate that the funds provided by the bill are not intended to 
be the sole source of funding for hypodermic apparatus exchange programs. It adds 
language to clarify that the intent of the bill is not to limit securing other sources of 
funding. 
2. It establishes the same methodology for distributing funds for both existing and 
new programs. 
3. It requires funds appropriated in the bill to be awarded no later than 60 days after 
the effective date of the legislation. 
4. It removes the bill provisions related to restrictions on use of funds. 
5. It amends the rule-making authority of the Maine Center for Disease Control and 
Prevention to ensure that the center may amend the rules regulating the hypodermic 
COMMITTEE AMENDMENT 
~ e:,., 
~·l!'I 
COMMITTEE AMENDMENT "A" to H.P. 1057, L.D. 1552 
apparatus exchange programs with respect to the distribution of funds, renewal of 
certification, complaint investigation procedures and decertification criteria. 
FISCAL NOTE REQUIRED 
(See attached) 
COMMITTEE AMENDMENT 
\Ir 
,r, la,,·j_:v. 'i' 
1'
.~,a, 
.. c..· 
' 
... 
, ·" 
\ 
~~0· 
'~.l_~-y· 
Approved: 03/03/16 feac 
LD 1552 
LR 2590(02) 
An Act To Reduce Morbidity and Mortality Related tcdnjected Drugs 
Fiscal Note for Bill as Amended by Committee Amendment ''/J:i ( \-\ -5::>GJ 
Committee: Health and Human Services 
Net Cost (Savings) 
General Fund 
Appropriations/ Allocations 
General Fund 
Fiscal Detail and Notes 
Fiscal Note Required: Yes 
Fiscal Note 
FY 2015-16 
FY 2016-17 
$0 
$75,000 
$0 
$75,000 
Projections 
FY 2017-18 
$75,000 
$75,000 
Projections 
FY 2018-19 
$75,000 
$75,000 
The bill includes a General Fund appropriation to the Department of Health and Human Services of $75,000 in fiscal 
year 2016-17 to fund the existing and new hypodermic apparatus exchange programs certified by the Maine Center for 
Disease Control. 
LR2590(02) - Fiscal Note - Page 1 of 1